Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs” - SciTechDaily

1 week ago 3

Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs” SciTechDaily
Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
Weight-loss jabs linked to reduced hazard of 42 conditions including dementia The Guardian
Ozempic and akin value nonaccomplishment drugs whitethorn little hazard of 42 wellness conditions, but besides airs risks The Conversation
Popular GLP-1 medications whitethorn person wellness benefits that widen beyond value nonaccomplishment and humor sweetener control, a caller survey finds CNN

Read Entire Article